Mecoshore-P Tablet SR
Marketer
Cue Labs
Salt Composition
Methylcobalamin (750mcg) + Pregabalin (75mg)
Overview Mecoshore-P Tablet SR
Mecoshore-P SR tablets are a prescription medication for managing neuropathic pain. Their mechanism involves modulating nerve cell calcium channel activity to reduce pain signals. This medication also supports nerve fiber protection and the repair of damaged nerve cells. Mecoshore-P SR tablets are administered orally, with or without food, ideally before sleep. Consistent daily timing helps maintain stable blood levels. Always follow your physician's prescribed dosage and duration, as this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation should be avoided without consulting your doctor. Common side effects include upper respiratory infection, increased hunger, elevated mood, shaking, vision blurring, dry mouth, lightheadedness, and drowsiness. Refrain from driving or tasks demanding concentration until the medication's effects are understood. These side effects are typically mild and resolve over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal thoughts to your doctor. Disclose all other medications you are using, as interactions may reduce efficacy or alter the medication's action. Inform your doctor about pregnancy, pregnancy planning, or breastfeeding.
Uses of Mecoshore-P Tablet SR
Managing neuropathic pain
Major Benefits of Mecoshore-P Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Mecoshore-P Tablet SR whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
Common Side effects of Mecoshore-P Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Mecoshore-P Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Mecoshore-P Tablet SR whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.
How Mecoshore-P Tablet SR works:
Mecoshore-P SR tablets contain methylcobalamin and pregabalin, working synergistically to alleviate neuropathic pain. Methylcobalamin, a B vitamin, supports myelin sheath production, protecting and repairing nerve fibers. Pregabalin, an alpha-2-delta ligand, reduces pain signals by modulating nerve cell calcium channels. This combined action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mecoshore-P sustained-release tablets and alcohol can lead to significant sedation.
PregnancyCONSULT YOUR DOCTOR
Using Mecoshore-P Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Mecoshore-P tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving should be avoided if taking Mecoshore-P Tablet SR, as this medication can potentially induce drowsiness, visual disturbances, and dizziness, thereby reducing alertness.
KidneyCAUTION
Extended-release Mecoshore-P tablets require careful administration for individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Use of Mecoshore-P Tablet SR in patients with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Mecoshore-P Tablet SR :
Should you forget a Mecoshore-P Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mecoshore-P Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience (Central Nervous System) |


